Blog Article
Closing a seed or Series A round is a milestone. But for most early-stage MedTech founders, the conversation that follows almost immediately is the one about who to bring in first on the commercial side. It is one of the most consequential hiring decisions a company will make, and often one of the least structured.
The hire that sets the trajectory
Early-stage MedTech companies are not short on technical talent. Founders typically come from a clinical, engineering, or scientific background, and the early team reflects that. What changes after the first institutional round is the expectation: investors want to see commercial traction, and that requires someone who can build the foundation, not just execute against an existing one.
The right first commercial hire understands the regulatory environment well enough to position the product accurately, has the relationships to open the right doors at the right institutions, and can operate without the infrastructure a larger company would provide. That is a specific profile, and it is not always the most obvious one.
Why early-stage hiring works differently
At scale, hiring is largely a filtering exercise. At the seed or Series A stage, it is closer to a partnership decision. The person you bring in will shape your commercial strategy, your culture, and in many cases your investor narrative for the next two to three years. They will also be the person who builds out the team beneath them, which means their judgment on people matters as much as their functional expertise.
This makes the search genuinely different from a standard commercial recruitment. The criteria are harder to articulate, the candidate pool is smaller, and the stakes for a poor fit are higher. The best candidates for these roles are rarely actively looking. They are typically embedded in companies that value them, and they need a compelling reason to consider something earlier stage.
Starting the search at the right time
One of the most consistent patterns in early-stage MedTech hiring is that the search starts later than it should. Founders are focused on closing the round, and the hiring conversation gets pushed to after. By the time the funding is confirmed and the brief is written, three months have passed and the board is already asking about commercial progress.
The companies that move fastest tend to start thinking about this hire before the round closes, so that when capital arrives, the search is already in motion rather than just beginning.
Guided Solutions has supported early-stage MedTech companies across the full hiring journey, from the first commercial appointment through to building out complete teams. With 26 years of exclusive MedTech focus and a network of 180,000+ professionals, we know who is open to the right conversation, even when they are not looking.
